Annotation Detail

Information
Associated Genes
MGMT
Associated Variants
MGMT PROMOTER METHYLATION
MGMT PROMOTER METHYLATION
Associated Disease
glioblastoma
Source Database
CIViC Evidence
Description
MGMT promoter methylation has been shown to confer sensitivity to alkylating agents, such as carmustine, in glioblastoma cells.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/308
Gene URL
https://civic.genome.wustl.edu/links/genes/34
Variant URL
https://civic.genome.wustl.edu/links/variants/85
Rating
4
Evidence Type
Predictive
Disease
Glioblastoma Multiforme
Evidence Direction
Supports
Drug
Carmustine
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
11070098
Drugs
Drug NameSensitivitySupported
CarmustineSensitivitytrue